Augmenting GWAS with Retrotransposon Polymorphisms
利用逆转录转座子多态性增强 GWAS
基本信息
- 批准号:7943987
- 负责人:
- 金额:$ 50.7万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-09-30 至 2011-08-31
- 项目状态:已结题
- 来源:
- 关键词:3&apos Flanking RegionAddressAreaBiological AssayCancer EtiologyCatalogingCatalogsCopy Number PolymorphismCustomDataDetectionDiseaseElementsFamilyGene FrequencyGenetic DeterminismGenetic PolymorphismGenetic VariationGenomeGenomicsGenotypeHaplotypesHumanHuman GenomeIndividualInternationalLocationMalignant NeoplasmsMalignant neoplasm of prostateMethodsPopulationPositioning AttributeRepetitive SequenceRetroposonRetrotransposonRiskSNP genotypingSequence AnalysisSiteSourceStudy SubjectSystemTechniquesVariantbasecancer riskdesigndisease phenotypedisease-causing mutationgenome wide association studygenome-wideinsightneoplasticnext generationnovel markerresearch study
项目摘要
DESCRIPTION (provided by applicant):
This application addresses broad Challenge Area (08) Genomics and specific Challenge Topic, 08-CA-101: Augmenting Genome-Wide Association Studies. Genome-wide association studies (GWAS) are typically carried out to uncover potential correlations between SNP genotypes and disease phenotypes. Often, cancer or neoplastic conditions have been the subject of these studies, and they have provided useful insights into the genetic determinants of cancer etiology. While SNPs are the most common form of genetic variation, there are other forms such as copy number variation (CNV) and retrotransposon insertion polymorphisms (RIPs). Recently, GWAS incorporating CNV data have been completed with positive results, but to date no GWAS experiments have used RIPs as the genotypic marker despite the fact that active human families of retrotransposon (LINE-1, Alu, and SVA) are collectively responsible for over 60 disease-causing mutations. The reason for this omission of an important source of genomic variation has been largely technical: no large-scale detection method has enabled the cataloguing of RIPs. Recently, we have developed a robust method for the detection of human-specific LINE-1 (L1) insertions on a genome- wide scale using a hemi-specific PCR method to amplify L1 3' flanking regions in a manner amenable to next-generation sequencing on Illumina's Genome Analyzer platform. Subsequent analysis of the sequencing results reproducibly provides the location of human-specific L1 insertion locations. This technique can be readily extended to other forms of retrotransposon-induced variation including the Alu and SVA families of retroposons simply by interchanging the hemi- specific primer sequences. Once a significant amount of RIP-induced variation has been catalogued across several distinct populations, we will use these sites to design a genotyping array using Illumina's iSelect custom Infinium assay system. Using this array of RIP markers, we will then carry out a GWAS for prostate cancer on ~1000 cases and ~1000 controls. We fully expect to identify 4,000 or more RIP markers for this assay that will serve as an augmentation to GWAS studies in which RIPs have not yet been considered. Genome Wide Association Studies (GWAS) have proven their utility in identifying genomic variants associated with risk for many diseases. To date, SNPs and CNVs have been used as the variant markers in these studies, omitting a major contributor to Human variation: retrotransposon insertion polymorphisms (RIPs). We propose to use a technique we have developed which identifies RIPs on a genome-wide scale to collect a large number of RIP markers for a genotyping array and then conduct a GWAS on prostate cancer in a proof-of-concept attempt to identify new markers associated with the disease.
描述(由申请人提供):
这个应用程序解决了广泛的挑战领域(08)基因组学和特定的挑战主题,08-CA-101:增强全基因组关联研究。全基因组关联研究(GWAS)通常用于揭示SNP基因型与疾病表型之间的潜在相关性。通常,癌症或肿瘤状况一直是这些研究的主题,并且它们为癌症病因学的遗传决定因素提供了有用的见解。虽然SNP是遗传变异的最常见形式,但也有其他形式,如拷贝数变异(CNV)和反转录转座子插入多态性(RIP)。最近,GWAS纳入CNV数据已经完成了积极的结果,但迄今为止,没有GWAS实验使用RIP作为基因型标记,尽管事实上,活跃的人类逆转录转座子家族(LINE-1,Alu和SVA)共同负责超过60种致病突变。遗漏基因组变异的一个重要来源的原因主要是技术性的:没有大规模的检测方法能够对RIP进行编目。最近,我们已经开发了一种用于在全基因组规模上检测人特异性LINE-1(L1)插入的稳健方法,其使用半特异性PCR方法以适于在Illumina的基因组分析仪平台上进行下一代测序的方式扩增L1 3'侧翼区。测序结果的后续分析可重复地提供人特异性L1插入位置的位置。这种技术可以容易地扩展到其他形式的反转录转座子诱导的变异,包括Alu和SVA家族的反转录转座子,只需互换半特异性引物序列。一旦在几个不同的人群中编目了大量RIP诱导的变异,我们将使用这些位点来设计使用Illumina的iSelect定制Infinium检测系统的基因分型阵列。使用RIP标记物阵列,我们将对约1000例病例和约1000例对照进行前列腺癌的GWAS。我们完全期望为该检测鉴定4,000个或更多RIP标记物,这将作为GWAS研究的补充,其中尚未考虑RIP。全基因组关联研究(GWAS)已经证明了它们在鉴定与许多疾病风险相关的基因组变异方面的实用性。到目前为止,SNPs和CNV已被用作这些研究中的变异标记,忽略了人类变异的主要贡献者:反转录转座子插入多态性(RIP)。我们建议使用我们开发的一种技术,该技术在全基因组范围内识别RIP,以收集大量RIP标记物用于基因分型阵列,然后在前列腺癌上进行GWAS,以验证概念,尝试识别与疾病相关的新标记物。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
HAIG H. KAZAZIAN其他文献
Molecular Size Studies on 6-Phosphogluconate Dehydrogenase
6-磷酸葡萄糖酸脱氢酶的分子大小研究
- DOI:
10.1038/212197a0 - 发表时间:
1966-10-08 - 期刊:
- 影响因子:48.500
- 作者:
HAIG H. KAZAZIAN - 通讯作者:
HAIG H. KAZAZIAN
Identity of different mutations for deleterious genes (reply)
有害基因不同突变的特性(回复)
- DOI:
10.1038/301176b0 - 发表时间:
1983-01-13 - 期刊:
- 影响因子:48.500
- 作者:
HAIG H. KAZAZIAN;ARAVINDA CHAKRAVARTI;STUART H. ORKIN - 通讯作者:
STUART H. ORKIN
HAIG H. KAZAZIAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('HAIG H. KAZAZIAN', 18)}}的其他基金
The role of retrotransposons in autism spectrum disorders
逆转录转座子在自闭症谱系障碍中的作用
- 批准号:
8046942 - 财政年份:2010
- 资助金额:
$ 50.7万 - 项目类别:
Augmenting GWAS with Retrotransposon Polymorphisms
利用逆转录转座子多态性增强 GWAS
- 批准号:
7811559 - 财政年份:2009
- 资助金额:
$ 50.7万 - 项目类别:
相似海外基金
Influence of the polymorphism of 5'-flanking region of SAA1 gene on SAA1 transcriptional activity
SAA1基因5侧翼区多态性对SAA1转录活性的影响
- 批准号:
13670479 - 财政年份:2001
- 资助金额:
$ 50.7万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Characterization of The 5'-Flanking Region of the Stress Response Gene, Osp94
应激反应基因 Osp94 5-侧翼区域的表征
- 批准号:
12672132 - 财政年份:2000
- 资助金额:
$ 50.7万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Mdecular cloning and analysis of S' -flanking region of human MYPT1 gene
人MYPT1基因S侧翼区的分子克隆与分析
- 批准号:
10670645 - 财政年份:1998
- 资助金额:
$ 50.7万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
ANALYSIS OF CYCLIN D1 GENE EXPRESSION BY METHYLATION OF CpG ISLAND LOCATED 5'-FLANKING REGION
5-侧翼区 CpG 岛甲基化分析细胞周期蛋白 D1 基因表达
- 批准号:
09670226 - 财政年份:1997
- 资助金额:
$ 50.7万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
ANALYSIS OF TWO PROMOTERS AND 5'FLANKING REGION OF RAT SERINE : PYRUVATE AMINOTRANSFERASE GENE
大鼠丝氨酸丙酮酸转氨酶基因的两个启动子和5侧翼区的分析
- 批准号:
05680546 - 财政年份:1993
- 资助金额:
$ 50.7万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
Characterization of 5 prime flanking region of 230 kDa bullous pemphigoid antigen gene
230 kDa 大疱性类天疱疮抗原基因 5 主要侧翼区域的表征
- 批准号:
05670718 - 财政年份:1993
- 资助金额:
$ 50.7万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
Syndrome of extreme insulin resistance due to decreased promoter activity of 5'-flanking region of insulin receptor gene.
由于胰岛素受体基因 5-侧翼区域启动子活性降低而导致的极端胰岛素抵抗综合征。
- 批准号:
03454513 - 财政年份:1991
- 资助金额:
$ 50.7万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)